Cargando…

Carbohydrate‐induced weight gain models for diabetes research: Contribution of incretins and parasympathetic signal

Detalles Bibliográficos
Autores principales:	Seino, Yusuke, Murase, Masatoshi, Hayashi, Yoshitaka, Suzuki, Atsushi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779273/ https://www.ncbi.nlm.nih.gov/pubmed/32618108 http://dx.doi.org/10.1111/jdi.13342

Ejemplares similares

Short-Term High-Starch, Low-Protein Diet Induces Reversible Increase in β-cell Mass Independent of Body Weight Gain in Mice
por: Masuda, Atsushi, et al.
Publicado: (2019)

Functional adenosine triphosphate‐sensitive potassium channel is required in high‐carbohydrate diet‐induced increase in β‐cell mass
por: Murase, Masatoshi, et al.
Publicado: (2018)

Carbohydrate‐induced secretion of glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1
por: Seino, Yusuke, et al.
Publicado: (2016)

GIP: An Inconsequential Incretin or Not?
por: Pratley, Richard E.
Publicado: (2010)

Incretin concept revised: The origin of the insulinotropic function of glucagon‐like peptide‐1 – the gut, the islets or both?
por: Yabe, Daisuke, et al.
Publicado: (2017)

Effect of post-exercise ingestion of different molecular weight carbohydrate solutions. Part II: The incretin response
por: Anzalone, Anthony J, et al.
Publicado: (2015)

β‐Cell glutamate signaling: Its role in incretin‐induced insulin secretion
por: Yokoi, Norihide, et al.
Publicado: (2016)

Stimulatory effect of imeglimin on incretin secretion
por: Yingyue, Quan, et al.
Publicado: (2023)

GIP and GLP‐1, the two incretin hormones: Similarities and differences
por: Seino, Yutaka, et al.
Publicado: (2010)

The journey to understanding incretin systems: Theory, practice and more theory
por: Yabe, Daisuke, et al.
Publicado: (2019)

Cardiovascular safety trials of incretin‐based drugs: What do they mean?
por: Yabe, Daisuke, et al.
Publicado: (2016)

Incretin hormones and the satiation signal
por: Holst, J J
Publicado: (2013)

Cardiac Sympathetic-Parasympathetic Interaction: The Endless Story of Yin and Yang
por: Dusi, Veronica, et al.
Publicado: (2020)

Signals and Noise in Drug Safety Analyses: The incretin therapy debate provides the rationale for revamping epidemiologic pharmacovigilance
por: Cefalu, William T., et al.
Publicado: (2013)

Comparison of incretin immunoassays with or without plasma extraction: Incretin secretion in Japanese patients with type 2 diabetes
por: Yabe, Daisuke, et al.
Publicado: (2011)

Parasympathetic control of gastrointestinal motility and cross-branch actions of parasympathetic neuromodulation
por: Chen, Jiande DZ
Publicado: (2023)

Cardiovascular effects of the incretin-based therapy: the good, the bad, or the ugly?
por: Cho, Young Min
Publicado: (2015)

Incretin‐based drugs for type 2 diabetes: Focus on East Asian perspectives
por: Seino, Yutaka, et al.
Publicado: (2016)

The Incretin Effect in Female Mice With Double Deletion of GLP-1 and GIP Receptors
por: Ahrén, Bo, et al.
Publicado: (2019)

Assessments of Heart Rate and Sympathetic and Parasympathetic Nervous Activities of Normal Mouse Fetuses at Different Stages of Fetal Development Using Fetal Electrocardiography
por: Kasahara, Yoshiyuki, et al.
Publicado: (2021)

Glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1: Incretin actions beyond the pancreas
por: Seino, Yutaka, et al.
Publicado: (2013)

Incretin-Based Therapy and the Quest for Sustained Improvements in β-Cell Health
por: Drucker, Daniel J.
Publicado: (2011)

Incretin - based therapy in diabetes mellitus: present scenario and expanding horizons
por: Kohli, Suresh Chandra
Publicado: (2016)

Regulation of amino acid metabolism and α‐cell proliferation by glucagon
por: Hayashi, Yoshitaka, et al.
Publicado: (2018)

Nutritional Strategies to Prevent Weight Gain and Obesity
por: Allman-Farinelli, Margaret
Publicado: (2023)

Weight gain on dolutegravir: Association is not the same as causation
por: Maartens, Gary, et al.
Publicado: (2023)

Luseogliflozin Additively Enhances the Glucose-Lowering Effect of an Incretin Modulator in a High-Carbohydrate Diet
por: Lee, Gendai
Publicado: (2022)

Incretin Concepts
por: Bloomgarden, Zachary T.
Publicado: (2010)

Inflammation and incretins
por: Hatwal, Amitabh
Publicado: (2012)

Establishment of new clonal pancreatic β‐cell lines (MIN6‐K) useful for study of incretin/cyclic adenosine monophosphate signaling
por: Iwasaki, Masahiro, et al.
Publicado: (2010)

The Timing of Rapid Infant Weight Gain in Relation to Childhood Obesity
por: Shin, Young-Lim
Publicado: (2019)

Primary Prevention of Weight Gain Is Essential to Promote Cardiovascular Health
por: Anderson, Cheryl A. M., et al.
Publicado: (2019)

Why Does Weight Gain Put More Stress on Women?
por: Cho, Young Gyu
Publicado: (2020)

Nrf2 contributes to the weight gain of mice during space travel
por: Suzuki, Takafumi, et al.
Publicado: (2020)

Essential roles of aspartate aminotransferase 1 and vesicular glutamate transporters in β-cell glutamate signaling for incretin-induced insulin secretion
por: Murao, Naoya, et al.
Publicado: (2017)

Translating Translational Research into Global Health Gains
Publicado: (2013)

Dietary recommendations for type 2 diabetes patients: Lessons from recent clinical and basic research in Asia
por: Seino, Yusuke, et al.
Publicado: (2019)

Incretin hormone responses to carbohydrate and protein/fat are preserved in adults with sulfonylurea‐treated KCNJ11 neonatal diabetes
por: Bowman, Pamela, et al.
Publicado: (2023)

Seasonality of Children’s Height and Weight and Their Contribution to Accelerated Summer Weight Gain
por: Moreno, Jennette P., et al.
Publicado: (2022)

Parasympathetic Cholinergic and Neuropeptide Mechanisms of Migraine
por: Mikhailov, Nikita, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_fctj4ja8os9fvjbdaieuoegcie